A study in mice suggests that birth is a “critical period” in Rett syndrome…
Ana Pena, PhD
Ana is a molecular biologist with a passion for discovery and communication. As a science writer she looks for connecting the public, in particular patient and healthcare communities, with clear and quality information about the latest medical advances. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in genetics, molecular biology, and infectious diseases.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Subtle but apparent signs of disease may precede the onset of overt symptoms in children with Rett syndrome…
A recombinant version of MeCP2 — the faulty protein in Rett syndrome — has the potential to enter…
Loss of MECP2, the defective protein in most people with Rett syndrome, induces premature growth arrest of bone…
Cannabidivarin, a non-psychotic compound found in cannabis, fully rescued memory deficits and delayed the appearance of neurological and…
Some people with Rett syndrome have an overabundance of nerve fibers associated with the…
Physical therapy and other medical interventions, together with daily support from family and caregivers, can help adults with…
Investigational therapy trofinetide showed promising safety and efficacy results as a treatment for children and adolescents…
Discovery and development of therapies for Rett syndrome requires better preclinical research practices and…